KPMG UK: Impact and value of the NIHR Clinical Research Network

Author Kym Lang
Posted 2019.11.22 Comments 0

KPMG UK: Impact and value of the NIHR Clinical Research Network

 

This report evaluates the value of clinical research to the NHS, and shows that over a three year period, clinical research supported by the NIHR CRN generated an estimated £8bn of gross value added and 47,467 full-time equivalent jobs for the UK.

The report, produced by KPMG UK’s Economics team and commissioned by the NIHR CRN, covers the financial period 2016/17 to 2018/19 and presents amalgamated three year data alongside figures for each individual financial year (FY). It shows that over this three year period, clinical research supported by the NIHR CRN generated an estimated £8bn of gross value added (GVA) and 47,467 full time equivalent (FTE) jobs for the UK.

Using data from a range of sources, the report also provides an insight into the benefits and income that NHS providers gain through undertaking commercial contract research - studies sponsored by life sciences companies and delivered alongside NHS care. The report provides an analysis of the value of payments to NHS trusts for delivering commercial research studies. It also estimates how much NHS providers save through using medicines provided as part of commercial studies, where the company bears the cost of the medicine, in place of the standard NHS treatment.

 

Full report